Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002· review· en· American Journal of Psychiatry· Medicine
aff
2,792
citations
Works
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Route
Field
Type
Language
Year range
to
Screen consensus
Sort
Flags
Screening evidence
Direct labels are sparse and unvalidated. Missing labels are unknown.
1 filter active
2,744 workspage 1 of 110
International Consensus Study of Antipsychotic Dosing
2010· article· en· American Journal of Psychiatry· Medicine
aff
1,305
citations
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis
2015· review· en· World Psychiatry· Medicine
fundno aff
1,244
citations
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
2012· article· en· Bipolar Disorders· Medicine
afffundabout
1,216
citations
Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis
2001· review· en· American Journal of Psychiatry· Medicine
aff
1,129
citations
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000· article· en· American Journal of Psychiatry· Medicine
aff
1,083
citations
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
2018· review· en· Biological Psychiatry· Medicine
affno abstract
990
citations
Atypical Antipsychotics: Mechanism of Action
2002· article· en· The Canadian Journal of Psychiatry· Medicine
affvenueabout
901
citations
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis
2005· article· en· Archives of General Psychiatry· Medicine
aboutno aff
804
citations
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012· review· en· The World Journal of Biological Psychiatry· Medicine
aff
636
citations
Half a century of antipsychotics and still a central role for dopamine D2 receptors
2003· review· en· Progress in Neuro-Psychopharmacology and Biological Psychiatry· Medicine
afffundno abstract
635
citations
Antipsychotic Drug Use and Mortality in Older Adults with Dementia
2007· article· en· Annals of Internal Medicine· Medicine
aboutno aff
625
citations
Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk
2014· article· en· Biological Psychiatry· Medicine
affno abstract
609
citations
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
2005· review· en· The International Journal of Neuropsychopharmacology· Medicine
aff
604
citations
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
2009· article· en· Bipolar Disorders· Medicine
affabout
569
citations
Risperidone in the Treatment of Disruptive Behavioral Symptoms in Children With Autistic and Other Pervasive Developmental Disorders
2004· article· en· PEDIATRICS· Neuroscience
aff
568
citations
N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
2008· article· en· Biological Psychiatry· Biochemistry, Genetics and Molecular Biology
affno abstract
546
citations
Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis
2020· review· en· Systematic Reviews· Medicine
aboutno aff
539
citations
From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis
2005· review· en· Schizophrenia Research· Neuroscience
afffundno abstract
509
citations
Cannabidiol: An Overview of Some Pharmacological Aspects
2002· review· en· The Journal of Clinical Pharmacology· Medicine
aff
506
citations
Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy
2003· article· en· Journal of Pharmacology and Experimental Therapeutics· Neuroscience
afffundno abstract
478
citations
Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or Haloperidol
2000· article· en· Archives of General Psychiatry· Medicine
aff
469
citations
Modern antipsychotic drugs: a critical overview
2005· review· en· Canadian Medical Association Journal· Medicine
afffundvenue
418
citations
Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
2005· article· en· Schizophrenia Research· Medicine
affno abstract
416
citations
Medication adherence of individuals with a first episode of psychosis
2002· article· en· Acta Psychiatrica Scandinavica· Medicine
aff
412
citations